Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Marijuana Use

Chen CY, Wagner FA, Anthony JC Marijuana use and the risk of major depressive episode epidemiological evidence from the United States National Comorbidity Survey. Soc Psychiatry Psychiatr Epidemiol 37 199-206, 2002... [Pg.176]

Compton WM, Grant BF, Colliver JD, et al Prevalence of marijuana use disorders in the United States 1991-1992 and2001-2002. JAMA291 2114-2121,2004 Cook SA, Lowe JA, Martin BR CBl receptor antagonist precipitates withdrawal in mice exposed to delta9-tetrahydrocannabinol. J Pharmacol Exp Ther 285 1150— 1156, 1998... [Pg.177]

Cornelius JR, Salloum IM, EhlerJG, et al Fluoxetine in depressed alcoholics a doubleblind, placebo-controlled trial. Arch Gen Psychiatry 54 700—705, 1997 Cornelius JR, Salloum IM, Haskett RF, et al Fluoxetine versus placebo for the marijuana use of depressed alcoholics. Addict Behav 24 111—114, 1999 Cui S-S, Bowen RC, Gu G-B, et al Prevention of cannabinoid withdrawal syndrome by lithium involvement of oxytocinergic neuronal activation. J Neurosci 21 9867— 9876, 2001... [Pg.177]

Kouri EM, Pope HG Jr Abstinence symptoms during withdrawal from chronic marijuana use. Exp Clin Psychopharmacol 8 483 92, 2000... [Pg.179]

Kouri EM, Pope HG Jr, Lukas SE Changes in aggressive behavior during withdrawal from long-term marijuana use. Psychopharmacology 143 302-308, 1999... [Pg.179]

Parker LA, Gillies T THC-induced place and taste aversions in Lewis and Sprague-Dawley rats. Behav Neurosci 109 71-78, 1995 Pope HG, Yurgelun-Todd D The residual cognitive effects of heavy marijuana use in college students. JAMA 275 521-327, 1996 Robson P Therapeutic aspects of cannabis and cannabinoids. BrJ Psychiatry 178 107-115, 2001... [Pg.180]

J Consult Clin Psychol 61 1100—1104, 1993 Stephens RS, Roffman RA, Simpson EE Treating adult marijuana dependence a test of the relapse prevention model. J Consult Clin Psychol 62 92—99, 1994 Stephens RS, Roffman RA, Curtin L Comparison of extended versus brief treatments for marijuana use. J Counsul Clin Psychol 68 898—908, 2000 Substance Abuse and Mental Health Services Administration The BASIS Report Marijuana Treatment Admissions Increase 1993-1999. Rockville, MB, Substance Abuse and Mental Health Services Administration, 2002a Substance Abuse and Mental Health Services Administration Results from the 2001 National Household Survey on Brug Abuse Vol I. Summary of National Findings. Rockville, MB, Substance Abuse and Mental Health Services Administration, 2002b... [Pg.180]

Substance Abuse and Mental Health Services Administration The BASIS Report Marijuana Use Secondary to Other Substances of Abuse. Rockville, MB, Substance Abuse and Mental Health Services Administration, 2003 Tanda G, Munzar P, Goldberg SR Self-administration behaviour is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nat Neurosci 3 1073— 1074, 2000... [Pg.180]

Epstein-Barr virus Human T-lymphocyte virus (HTFV-1 and HTFV-2) Social Habits Cigarette smoking Maternal marijuana use Maternal ethanol use... [Pg.1398]

Keeler MH and Reifler CB (1967). Grand mal convulsions subsequent to marijuana use. Diseases of the Nervous System, 18, 474-475. [Pg.270]

Kolansky H and Moore WT (1972). Toxic effects of marijuana use. Journal of the American... [Pg.271]

Loeber RT and Yurgelun-Todd DA (1999). Human neuroimaging of acute and chronic marijuana use Implications for frontocerebellar dysfunction. Human Psychopharmacology Clinical and Experimental, 14, 291-304. [Pg.272]

Pope HG and Yurgelun-Todd D (1996). The residual cognitive effects of heavy marijuana use in college students. Journal of the American Medical Association, 275, 521-527. [Pg.279]

In addition, societal expectations about substance use seem to be related to the susceptibility of societal members to experience drug-related problems. Many respected researchers believe that exposure to responsible substance use in society early in life may promote more moderate substance use in those societies where such behavior is sanctioned. One striking example is the Netherlands, which legalized marijuana use in coffee shops two decades ago but currently has lower marijuana abuse rates than the United States. We have no idea whether this kind of societal exposure would work with more potent substances than marijuana, although the same results have been found for alcohol in France, which has a much lower cirrhosis rate than the United States even... [Pg.24]

One very interesting research study used what was called a marijuana checkup to encourage people in the community to seek an assessment of their marijuana use (Stephens, Roffman, Curtin, 2000). The study was advertised as a way for marijuana users to get a check-up to make sure their marijuana use was not causing any unseen problems. When the person arrived at the center, he or... [Pg.162]

Stephens, R. S., Roffman, R. A., Curtin, L. (2000). Comparison of extended versus brief treatments for marijuana use. Journal of Consulting and Clinical Psychology, 68, 898-908. [Pg.307]

The major psychoactive constituent in marijuana use is A -tetrahydrocannabinol (THC), the prototypical can-nabinoid. Although marijuana contains a large number of cannabinoids, they lack behavioral activity with the exception of cannabinol, which is approximately one-tenth as potent as THC. The THC content in hashish is more than double that in marijuana. [Pg.416]

Millson, S. Walmsley, and R. Bendayan. Medicinal and recreational marijuana use by patients infected with... [Pg.107]

Prentiss, D., R. Power, G. Balmas, G. Tzuang, and D. M. Israelski. Patterns of marijuana use among patients with HIV/AIDS followed in a public health care setting. J Acquir Immune Defic Syndr 2004 35(1) 38-45. [Pg.108]

Fried, P., B. Watkinson, D. James, and R. Gray. Current and former marijuana use preliminary findings of a longitudinal study of effects on IQ in young adults. CMAJ 2002 166(7) 887-891. [Pg.111]

Donovan et al. (1996, 1997) completed an open study evaluating the use of valproic acid (Depakote) in adolescent outpatients with marijuana abuse or dependence and explosive mood disorder (mood symptoms were not classified using the DSM FV Diagnostic System). Eight subjects were prescribed 1000 mg of valproic acid (Depakote) for 5 weeks, in addition to regular therapy sessions, but did not receive any other psychotropic medications. All subjects showed a significant improvement in their marijuana use (p <0.007) and their affective symptoms (p < 0.001), although both outcomes were measured only by self-report. The most common adverse events were nausea and sedation. No subjects discontinued because of these side effects, nor were there any reported interactions between the valproic acid (Depakote) and substances of abuse. [Pg.607]

Significant decline in amount of marijuana used per week [p <... [Pg.608]

Budney AJ, Bickel WK Amass L (1998). Marijuana use and treatment outcome among opioid-dependent patients. Addiction, 93, 493-503... [Pg.151]

See other pages where Marijuana Use is mentioned: [Pg.171]    [Pg.172]    [Pg.174]    [Pg.214]    [Pg.82]    [Pg.98]    [Pg.919]    [Pg.921]    [Pg.841]    [Pg.163]    [Pg.163]    [Pg.29]    [Pg.76]    [Pg.84]    [Pg.229]    [Pg.417]    [Pg.115]    [Pg.610]    [Pg.97]    [Pg.97]    [Pg.56]    [Pg.170]   


SEARCH



Marijuana

© 2024 chempedia.info